HeartHealth: Improving Heart Health in Appalachia

Sponsor
Debra Moser (Other)
Overall Status
Completed
CT.gov ID
NCT01884246
Collaborator
University of Kentucky Center for Excellence in Rural Health-Hazard (Other)
330
1
2
41
8

Study Details

Study Description

Brief Summary

Individuals in Appalachian Kentucky are vulnerable to cardiovascular disease (CVD) by virtue of having high rates of multiple CVD risk factors. There is a critical need to develop and test CVD risk reducing interventions that are appropriate and effective in Appalachia. In the absence of such interventions, the dramatic CVD disparities seen in this area will continue to rise.

Lifestyle interventions reduce CVD risk by 44%. The investigators and others have demonstrated that lifestyle change is most effective when patients are given the tools to engage in effective self-care, and that interventions individualized to patients' specific needs and barriers are more effective than interventions that are not. The central hypothesis is that to be successful in Appalachia, CVD risk reducing interventions must focus on patient-centered lifestyle change that increase individuals' abilities to engage in self-care, must be culturally appropriate, and must have components that overcome barriers faced by individuals living in Appalachia.

The investigators propose a randomized, controlled comparative effectiveness trial with 300 individuals from Appalachian Kentucky who do not have a primary care provider and who are at risk for CVD by virtue of having two or more modifiable CVD risk factors. The investigators will compare (1) a patient-centered, culturally appropriate, self-care CVD risk reduction intervention (HeartHealth) designed to improve multiple CVD risk factors while overcoming barriers to success with (2) referral of patients to a primary care provider for management of their CVD risk factors. The investigators propose the following specific aims to be tested at 4 months and 1 year after baseline. To compare the short and long-term impact of the interventions on:

  1. the risk factor selected by patients (i.e., tobacco use, blood pressure, lipid profile, hemoglobin-A1c (HgA1c) for diabetics, body mass index, waist circumference, depressive symptoms, or physical activity level); 2) all of the CVD risk factors of each patient; 3) quality of life; 4) patient and healthcare provider satisfaction; 5) desirability and adoptability by assessing adherence to recommended CVD risk reduction measures, and retention of recruited individuals. The investigators hypothesize that in comparison to the referral strategy, the multifaceted patient-centered, self-care intervention will engender more favorable outcomes across all measures.
Condition or Disease Intervention/Treatment Phase
  • Behavioral: Self-care CVD risk reduction
  • Other: Referral to primary care provider for CVD risk management
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
330 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Reducing Health Disparities in Appalachians With Multiple Cardiovascular Disease Risk Factors
Actual Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Dec 31, 2016
Actual Study Completion Date :
Dec 31, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Self-care CVD risk reduction

A patient-centered, culturally appropriate lifestyle approach to promoting self-care in high risk patients.

Behavioral: Self-care CVD risk reduction
A patient-centered, culturally appropriate lifestyle approach to promoting self-care in high risk patients.
Other Names:
  • HeartHealth
  • Other: Referral to primary care provider for CVD risk management
    The study team provides a primary care provider for the patient, makes the referral and sends appropriate CVD risk reduction guidelines to the provider.

    Active Comparator: Referral to primary care provider

    The study team provides a primary care provider for the patient, makes the referral and sends appropriate CVD risk reduction guidelines to the provider.

    Other: Referral to primary care provider for CVD risk management
    The study team provides a primary care provider for the patient, makes the referral and sends appropriate CVD risk reduction guidelines to the provider.

    Outcome Measures

    Primary Outcome Measures

    1. cardiovascular risk factor selected by patient [4 months]

      Patient selects their own risk reduction goal from the following: smoking, blood pressure, lipid profile, body mass index, hemoglobin-A1c for diabetics, depression, physical activity level, waist circumference

    2. cardiovascular risk factor selected by patient [12 months]

      Patient selects their own risk reduction goal from the following: smoking, blood pressure, lipid profile, body mass index, hemoglobin-A1c for diabetics, depression, physical activity level, waist circumference

    Secondary Outcome Measures

    1. all CVD risk factors of each patient [4 months]

      All CVD risk factors that each patient has are secondary outcomes

    2. all CVD risk factors of each patient [12 months]

      All CVD risk factors that each patient has are secondary outcomes

    Other Outcome Measures

    1. quality of life [4 months]

    2. quality of life [12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • residents of eastern Appalachian Kentucky

    • do not have a primary care provider

    • at risk for CVD as reflected by having two or more of the following modifiable risk factors

    1. clinical diagnosis of hypertension or taking medications diagnosed for hypertension or found to be hypertensive on screening;

    2. clinical diagnosis of hyperlipidemia or taking medication for treating abnormal lipid levels, or any lipid abnormality found on screening that indicates hyperlipidemia;

    3. diagnosis of type 2 diabetes or HgA1c > 7% found on screening;

    4. overweight or obese (body mass index ≥ 25 kg/m2);

    5. waist circumference > 40 inches in men or > 35 inches in women;

    6. clinical diagnosis of depression, on medications for depression or found to have depressive symptoms (score of > 9 on the Patient Health Questionnaire-9) by baseline screening;

    7. sedentary lifestyle meaning that the individual does not engage in at least 30 minutes of moderate activity for at least 4 days per week

    Exclusion Criteria:
    • known coronary artery disease, cerebrovascular disease, history of acute coronary syndrome or peripheral arterial disease;

    • taking medications (e.g., protease inhibitors) that interfere with lipid metabolism;

    • cognitive impairment that precludes an individual from understanding the consent process, answering questionnaires, or participating in the intervention;

    • chronic drug abuse;

    • end-stage renal or liver or pulmonary disease;

    • current active cancer (i.e., undergoing active treatment for cancer) other than isolated skin cancer treatable by simple excision;

    • gastrointestinal disease that requires special diets (e.g., Crohn's disease; celiac disease)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Kentucky Lexington Kentucky United States 40535

    Sponsors and Collaborators

    • Debra Moser
    • University of Kentucky Center for Excellence in Rural Health-Hazard

    Investigators

    • Principal Investigator: Debra K Moser, DNSc, RN, University of Kentucky

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Debra Moser, Professor, University of Kentucky
    ClinicalTrials.gov Identifier:
    NCT01884246
    Other Study ID Numbers:
    • PCORI 3048110484
    First Posted:
    Jun 21, 2013
    Last Update Posted:
    Mar 10, 2017
    Last Verified:
    Mar 1, 2017
    Keywords provided by Debra Moser, Professor, University of Kentucky
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 10, 2017